Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Febrile NeutropeniaSarcomaDoxorubicin Adverse ReactionHospitalization-Associated Infection
Interventions
DEVICE

Acupuncture

Acupuncture will be administered bilaterally on points PC6, LI 4, CV6, SP6, SP10 and ST36 on the first day of each cycle (d1), prior to administration of chemotherapy; and on d8, each session lasting between 30 to 45 minutes. Patients will continue from d1 to d8 with press-tack acupuncture needles on points PC 6, LI4, SP 6 and ST 36. On d8, patients will again undergo acupuncture, and continue with self-acupressure on the same points as the press-tack needles, until the next chemotherapy cycle.

Trial Locations (1)

91031

Shaare Zedek Medical Center, Jerusalem

All Listed Sponsors
lead

Shaare Zedek Medical Center

OTHER

NCT06500715 - Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma | Biotech Hunter | Biotech Hunter